These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29879181)

  • 21. Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus.
    Wang ZS; Song ZC; Bai JH; Li F; Wu T; Qi J; Hu J
    Vasc Health Risk Manag; 2013; 9():237-43. PubMed ID: 23690689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
    Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus.
    Najafi L; Malek M; Valojerdi AE; Aghili R; Khamseh ME; Fallah AE; Tokhmehchi MR; Behrouz MJ
    J Diabetes Complications; 2013; 27(5):459-62. PubMed ID: 23726741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications.
    Saxena R; Madhu SV; Shukla R; Prabhu KM; Gambhir JK
    Clin Chim Acta; 2005 Sep; 359(1-2):101-8. PubMed ID: 15893742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
    Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus.
    Jung CH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO
    Nutr Res; 2016 Feb; 36(2):117-24. PubMed ID: 26826427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
    Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
    Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.
    Wang C; Wan S; Yang T; Niu D; Zhang A; Yang C; Cai J; Wu J; Song J; Zhang CY; Zhang C; Wang J
    Sci Rep; 2016 Feb; 6():20032. PubMed ID: 26831044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
    Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
    Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 2 expression on monocytes and microvascular complications in type 2 diabetic patients.
    Badr RE; Salama MI; Abd-Elmaogood AK; Eldeib AEM
    Diabetes Metab Syndr; 2019; 13(2):1299-1302. PubMed ID: 31336481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocyte glutathione concentration and production during hyperinsulinemia, hyperglycemia, and endotoxemia in healthy humans.
    van der Crabben SN; Stegenga ME; Blümer RM; Ackermans MT; Endert E; Tanck MW; Serlie MJ; van der Poll T; Sauerwein HP
    Metabolism; 2011 Jan; 60(1):99-106. PubMed ID: 20850847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hamilton rating scale for depression-24 (HAM-D
    Pan S; Liu ZW; Shi S; Ma X; Song WQ; Guan GC; Zhang Y; Zhu SM; Liu FQ; Liu B; Tang ZG; Wang JK; Lv Y
    Psychiatry Res; 2017 Dec; 258():177-183. PubMed ID: 28774662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
    Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
    Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
    Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
    Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.